Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Taxane-induced Peripheral Neuropathy 1Sarcopenia 1Peripheral Nervous System Diseases 1Colonic Neoplasms 1

Interventions

pembrolizumab 563Specimen Handling 493Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 405Radiotherapy 353Bevacizumab 314Gemcitabine 313Paclitaxel 298Biopsy 292Drug Therapy 284Blood Specimen Collection 248Capecitabine 246Oxaliplatin 241fludarabine 239Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 206Dexamethasone 188Radiosurgery 182Standard of Care 159Rituximab 159Pemetrexed 156Surgical Procedures, Operative 148atezolizumab 146durvalumab 145Leucovorin 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Gloves, Surgical × Clear all
NCT07285356 2025-12-16

GLOX-PEN

AC Camargo Cancer Center

Phase NA Recruiting
84 enrolled
Gastrointestinal

Colonic Neoplasms, Peripheral Nervous System Diseases, Sarcopenia

NCT06464536 2025-05-16

ComPrendo

St.Gallen University of Applied Sciences

Phase NA Recruiting
114 enrolled

Taxane-induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡